Alpha Teknova, Inc. (TKNO) vs Tilray Brands, Inc. (TLRY)

Alpha Teknova, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Tilray Brands, Inc. is the larger, with a market value of $603.0M against $498.8M — 1.2× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 12.3% against 11.5%. Tilray Brands, Inc. has the higher net margin (−13.3% vs −38.4%) and the higher return on invested capital (−2.27% vs −16.9%). Across the 18 metrics below, Tilray Brands, Inc. leads on 11 and Alpha Teknova, Inc. on 7.

Valuation

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 11.45 0.50 2.25
P/B 7.99 0.29 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 48.33 12.29
EV/Sales 11.45 0.66 2.56
Earnings yield (3.32%) (26.15%) (2.99%)
Free cash flow yield (1.47%) (32.87%) 0.00%

Profitability

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Gross margin 34.60% 28.45% 53.94%
Operating margin (36.19%) (6.88%) 0.00%
Net margin (38.37%) (13.26%) 0.00%
Free cash flow margin (16.83%) (10.77%) 0.00%
Return on equity (24.19%) (7.87%) (0.40%)
Return on assets (16.25%) (5.52%) (3.32%)
Return on invested capital (16.93%) (2.27%) 0.00%

Growth

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 12.27% 11.46% 10.01%
EPS growth (last fiscal year) 43.86% 95.57% —
Revenue growth, 5-year CAGR 5.30% 7.82% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Debt to equity 0.21 0.24 0.05
Current ratio 4.49 2.21 2.31
Net debt to EBITDA 0.75 11.34 0.85

Dividend

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric TKNO TLRY Drug Manufacturers Specialty & Generic median
Market cap 498.76m 602.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack